We are live on
!
Find out more
Aptevo Therapeutics
APVO
APVO
hedge funds and large institutions have $15.8M invested in Aptevo Therapeutics in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
9% less capital invested
Capital invested by funds: $17.4M → $15.8M (-$1.59M)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Legal & General Group
London,
United Kingdom
|
-$815K |
| 2 |
FM
Fondren Management
Houston,
Texas
|
-$292K |
| 3 |
ECM
Element Capital Management
New York
|
-$158K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$121K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$95K |
